NAM
Needelman Asset Management Portfolio holdings
AUM
$46M
This Quarter Return
-0.41%
1 Year Return
+8.27%
3 Year Return
+30.64%
5 Year Return
+75.02%
10 Year Return
–
AUM
$46M
AUM Growth
+$46M
(-0.92%)
Cap. Flow
+$25.3K
Cap. Flow
% of AUM
0.05%
Top 10 Holdings %
Top 10 Hldgs %
40.01%
Holding
34
New
–
Increased
9
Reduced
15
Closed
–
Top Buys
| 1 |
Procter & Gamble
PG
|
$15.6K |
| 2 |
Bristol-Myers Squibb
BMY
|
$12.5K |
| 3 |
Johnson & Johnson
JNJ
|
$12.1K |
| 4 |
Intel
INTC
|
$11.2K |
| 5 |
IBM
IBM
|
$10.5K |
Top Sells
| 1 |
Apple
AAPL
|
$9.25K |
| 2 |
NCR Voyix
VYX
|
$8.24K |
| 3 |
Gilead Sciences
GILD
|
$8.15K |
| 4 |
Fluor
FLR
|
$6.1K |
| 5 |
Markel Group
MKL
|
$5.42K |
Sector Composition
| 1 | Financials | 24.87% |
| 2 | Healthcare | 22.49% |
| 3 | Technology | 17.59% |
| 4 | Consumer Staples | 10.78% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Wells Fargo
WFC
$263B
| $3.53M | 7.68% |
63,656
-40
| -0.1% | -$2.22K |
|
2
Rio Tinto
RIO
$102B
| $1.91M | 4.15% |
34,400
-40
| -0.1% | -$2.22K |
|
3
Microsoft
MSFT
$3.77T
| $1.77M | 3.85% |
17,940
-25
| -0.1% | -$2.47K |
|
|
4
IBM
IBM
$227B
| $1.76M | 3.82% |
12,561
+75
| +0.6% | +$10.5K |
|
5
AT&T
T
$209B
| $1.74M | 3.79% |
54,225
+115
| +0.2% | +$3.69K |
|
|
6
Gilead Sciences
GILD
$140B
| $1.56M | 3.39% |
22,015
-115
| -0.5% | -$8.15K |
|
7
UnitedHealth
UNH
$281B
| $1.54M | 3.35% |
6,272
-10
| -0.2% | -$2.45K |
|
|
8
Intel
INTC
$107B
| $1.54M | 3.34% |
30,886
+225
| +0.7% | +$11.2K |
|
9
Bank of America
BAC
$376B
| $1.53M | 3.33% |
54,336
| – | – |
|
10
JPMorgan Chase
JPM
$829B
| $1.52M | 3.31% |
14,618
| – | – |
|
11
Elevance Health
ELV
$71.8B
| $1.48M | 3.22% |
6,215
| – | – |
|
|
12
Fluor
FLR
$6.63B
| $1.42M | 3.08% |
29,055
-125
| -0.4% | -$6.1K |
|
|
13
Markel Group
MKL
$24.8B
| $1.4M | 3.05% |
1,295
-5
| -0.4% | -$5.42K |
|
14
Honeywell
HON
$139B
| $1.39M | 3.02% |
9,646
-15
| -0.2% | -$2.16K |
|
15
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.39M | 3.02% |
7,440
-20
| -0.3% | -$3.73K |
|
16
Diageo
DEO
$62.1B
| $1.32M | 2.88% |
9,182
| – | – |
|
17
AbbVie
ABBV
$372B
| $1.31M | 2.84% |
14,092
| – | – |
|
18
Abbott
ABT
$231B
| $1.29M | 2.8% |
21,132
| – | – |
|
19
Kimberly-Clark
KMB
$42.8B
| $1.27M | 2.77% |
12,083
| – | – |
|
20
Chevron
CVX
$324B
| $1.27M | 2.76% |
10,040
| – | – |
|
|
21
Johnson & Johnson
JNJ
$427B
| $1.26M | 2.75% |
10,410
+100
| +1% | +$12.1K |
|
22
Emerson Electric
EMR
$74.3B
| $1.22M | 2.66% |
17,705
-30
| -0.2% | -$2.07K |
|
23
Pfizer
PFE
$141B
| $1.11M | 2.42% |
30,665
+250
| +0.8% | +$9.07K |
|
|
24
Apple
AAPL
$3.45T
| $1.09M | 2.38% |
5,906
-50
| -0.8% | -$9.25K |
|
25
Aon
AON
$79.1B
| $1.03M | 2.25% |
7,525
| – | – |
|